Optimizing ATR inhibition and Cisplatin Synergy in Ewing Sarcoma
EWSR1::FLI1-mediated dysregulation of cellular machinery opens up potential new avenues for Ewing sarcoma treatment. A recent study demonstrates that pharmacologic ATR kinase inhibition dramatically synergizes with low-dose cisplatin through EWSR1::FLI1-dependent rewiring of transcription, DNA repai...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 August 2024
|
| In: |
Clinical cancer research
Year: 2024, Jahrgang: 30, Heft: 16, Pages: 3358-3360 |
| ISSN: | 1557-3265 |
| DOI: | 10.1158/1078-0432.CCR-24-1047 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-24-1047
|
| Verfasserangaben: | Shunya Ohmura and Thomas G.P. Grünewald |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1905218087 | ||
| 003 | DE-627 | ||
| 005 | 20241205180158.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 241009s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1158/1078-0432.CCR-24-1047 |2 doi | |
| 035 | |a (DE-627)1905218087 | ||
| 035 | |a (DE-599)KXP1905218087 | ||
| 035 | |a (OCoLC)1475314774 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Ohmura, Shunya |e VerfasserIn |0 (DE-588)1242678476 |0 (DE-627)1772775770 |4 aut | |
| 245 | 1 | 0 | |a Optimizing ATR inhibition and Cisplatin Synergy in Ewing Sarcoma |c Shunya Ohmura and Thomas G.P. Grünewald |
| 264 | 1 | |c 15 August 2024 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.10.2024 | ||
| 520 | |a EWSR1::FLI1-mediated dysregulation of cellular machinery opens up potential new avenues for Ewing sarcoma treatment. A recent study demonstrates that pharmacologic ATR kinase inhibition dramatically synergizes with low-dose cisplatin through EWSR1::FLI1-dependent rewiring of transcription, DNA repair, and translation machinery, which could maximize the therapeutic window of the combinatory therapy. | ||
| 700 | 1 | |a Grünewald, Thomas G. P. |d 1980- |e VerfasserIn |0 (DE-588)13673426X |0 (DE-627)585870365 |0 (DE-576)301246432 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical cancer research |d Philadelphia, Pa. [u.a.] : AACR, 1995 |g 30(2024), 16 vom: Aug., Seite 3358-3360 |h Online-Ressource |w (DE-627)325489971 |w (DE-600)2036787-9 |w (DE-576)094502234 |x 1557-3265 |7 nnas |a Optimizing ATR inhibition and Cisplatin Synergy in Ewing Sarcoma |
| 773 | 1 | 8 | |g volume:30 |g year:2024 |g number:16 |g month:08 |g pages:3358-3360 |g extent:3 |a Optimizing ATR inhibition and Cisplatin Synergy in Ewing Sarcoma |
| 856 | 4 | 0 | |u https://doi.org/10.1158/1078-0432.CCR-24-1047 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20241009 | ||
| 993 | |a Article | ||
| 994 | |a 2024 | ||
| 998 | |g 13673426X |a Grünewald, Thomas G. P. |m 13673426X:Grünewald, Thomas G. P. |d 910000 |d 912000 |e 910000PG13673426X |e 912000PG13673426X |k 0/910000/ |k 1/910000/912000/ |p 2 |y j | ||
| 998 | |g 1242678476 |a Ohmura, Shunya |m 1242678476:Ohmura, Shunya |d 50000 |e 50000PO1242678476 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1905218087 |e 458961880X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"3 S."}],"recId":"1905218087","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"note":["Gesehen am 09.10.2024"],"title":[{"title_sort":"Optimizing ATR inhibition and Cisplatin Synergy in Ewing Sarcoma","title":"Optimizing ATR inhibition and Cisplatin Synergy in Ewing Sarcoma"}],"origin":[{"dateIssuedDisp":"15 August 2024","dateIssuedKey":"2024"}],"person":[{"display":"Ohmura, Shunya","given":"Shunya","role":"aut","family":"Ohmura"},{"role":"aut","given":"Thomas G. P.","family":"Grünewald","display":"Grünewald, Thomas G. P."}],"relHost":[{"part":{"pages":"3358-3360","issue":"16","extent":"3","text":"30(2024), 16 vom: Aug., Seite 3358-3360","year":"2024","volume":"30"},"id":{"zdb":["2036787-9"],"eki":["325489971"],"issn":["1557-3265"]},"pubHistory":["1.1995 -"],"name":{"displayForm":["American Association for Cancer Research"]},"corporate":[{"role":"isb","display":"American Association for Cancer Research"}],"disp":"Optimizing ATR inhibition and Cisplatin Synergy in Ewing SarcomaClinical cancer research","recId":"325489971","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Clinical cancer research","title":"Clinical cancer research"}],"note":["Gesehen am 08.06.2023","Fortsetzung der Druck-Ausgabe"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"publisher":"AACR","dateIssuedKey":"1995","publisherPlace":"Philadelphia, Pa. [u.a.]","dateIssuedDisp":"1995-"}]}],"id":{"eki":["1905218087"],"doi":["10.1158/1078-0432.CCR-24-1047"]},"name":{"displayForm":["Shunya Ohmura and Thomas G.P. Grünewald"]}} | ||
| SRT | |a OHMURASHUNOPTIMIZING1520 | ||